Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line
- 1 May 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (2) , 188-199
- https://doi.org/10.1016/0090-8258(90)90332-f
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Tamoxifen therapy in advanced/recurrent endometrial carcinomaGynecologic Oncology, 1989
- In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetateGynecologic Oncology, 1988
- Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogensBiochemical and Biophysical Research Communications, 1987
- In vitro effects of tamoxifen on UM‐SCC head and neck cancer cell lines: Correlation with the estrogen and progesterone receptor contentInternational Journal of Cancer, 1987
- Endometrial carcinoma: Steroid receptors and response to medroxyprogesterone acetateGynecologic Oncology, 1985
- Steroid hormone receptors in human squamous carcinoma cell linesInternational Journal of Cancer, 1984
- Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: A clinical and histopathological study of 175 patientsGynecologic Oncology, 1984
- Tamoxifen as a possible chemotherapeutic agent in endometrial adenocarcinomaGynecologic Oncology, 1981
- Treatment of Advanced Endometrial Carcinoma with TamoxifenNew England Journal of Medicine, 1979
- Gestagens and endometrial carcinomaGynecologic Oncology, 1976